Knowledge Hub
Categories:
- Allergy [1]
- Antimicrobials & infection [5]
- Autoimmune [1]
- Chemical Pathology [15]
- Endocrinology [1]
- Epidemiology [3]
- Gastrointestinal [2]
- Genetics [6]
- Genitourinary [2]
- Haematology [9]
- HIV/TB [3]
- Infectious Diseases [10]
- Neurology [4]
- Obstetric and Neonatal care [4]
- Oncology [1]
- Ophthalmology [1]
- Respiratory [2]
- Serology [3]
- Virology [44]
With regard to Designated Service Provider (DSP) Contracts the following law is pertinent for service providers who are not a DSP:
- In terms of Section 59 (2) of the Medical Schemes Act 131 of 1998 the medical scheme must pay valid invoices within 30 days of receipt thereof or advise both the member and service provider of reasons why the invoice is not valid and provide the opportunity to correct the invoice.
- Where services are in respect of medical emergencies or involuntarily obtained services for PMB conditions, the scheme has to pay for the full cost of the services provided without deduction or co-payment or limiting the tariff amount. (Regulation 8 (1) of the Medical Schemes Act no. 131 of 1998.)
- DOH notice 214 of 2021 requires that a scheme pays for services provided at the same rate and in terms of the same rules as they pay their DSPs in respect of services voluntarily obtained, whether they are PMBs or not.
- The process followed in respect of appointing a DSP is required to be fair, equitable, transparent, competitive or cost effective as required in terms of Notice 214 of the DOH.
In summary:
- The law protects the patient’s choice to use their laboratory of choice, even if it is not a DSP, and the scheme is still obliged to reimburse us at the scheme rate for valid claims.
- This is true for PMB conditions as well as non-PMB conditions.
- The medical scheme must pay valid invoices within 30 days or advise both the member and service provider of reasons why the invoice is not valid and provide the opportunity to correct invoice.
- A scheme must pay for the services provided at a tariff not less than what they would pay a DSP.
- Should any patient have a valid claim rejected because we are not a DSP, we can assist.
Respiratory Pathogen Statistics July 2023
Influenza A detection rates continued to decline during July, dropping below 2% in week 30 (week ending 30 July).
Schistosomiasis/Bilharzia
Schistosomiasis (Bilharzia) is an intravascular parasitic infection caused by flukes (trematodes) of the genus Schistosoma.
Respiratory Virus Statistics June 2023
Influenza A detection rates peaked in week 21 and then decreased each week throughout June, with the percentage positivity dropping to 12% in the last week of June.
Polycystic Ovary Syndrome
Polycystic ovary syndrome (PCOS), is a common hormonal disorder among women of reproductive age, characterised by enlarged ovaries with cyst formation, ovulatory dysfunction, and/or elevated androgens
Understanding seasonal influenza virus types
Influenza viruses are constantly changing. Antigenic drift refers to small gene changes continually occurring during virus replication that leads to small HA and NA changes.
Cholera Outbreak 2023: Update and Reminders
While uncommon and NOT endemic to South Africa, the world is currently (and since 1961) experiencing the 7th global cholera outbreak according to historic record
with more than 50 countries having endemic cholera.
Respiratory Virus Statistics: April 2023
Respiratory syncytial virus (RSV) detection rates peaked in March and declined steadily during April across all age groups, with the exception of the 0-12 month olds where detection rates remained above 35% throughout April.
Mumps Virus Alert: South Africa 2023
Mumps virus (MV), a single-stranded RNA virus of the paramyxoiridae family, is highly contagious and is most commonly associated with parotitis. There has been a significant increase in the amount of mumps cases nationally in 2023
Respiratory virus statistics: March 2023
Following the start of the 2023 respiratory syncytial virus (RSV) season in week 6 (week ending 11 February), detection rates continued to increase during March, predominantly in the <5 year age group.